Back

Asymmetric and symmetric dimethylarginine in atrial fibrillation progression and recurrence

1 September 2019 (08:30 - 12:30)
Organised by:
Congress Presentation Part of: Poster Session 2 - Atrial fibrillation pathophysiology and mechanisms Pathophysiology and Mechanisms ESC Premium Access ESC Congress 2019

About the speaker

Photo
Doctor Petra Buettner

Heart Center of Leipzig, Leipzig (Germany)

9 More presentations in this session

Presentation thumbnail
Doctor E. Mironova (Moscow, RU)
Abstract Slides
Presentation thumbnail
Doctor T. Tu (Changsha, CN)
Abstract Slides
Presentation thumbnail
Professor G. Tse (Hong Kong, CN)
Abstract
Presentation thumbnail
Doctor N. Kazem (Vienna, AT)
Abstract Slides
Presentation thumbnail
Doctor M. Amioka (Hiroshima, JP)

Access the full session

Session thumbnail
Poster Session 2 - Atrial fibrillation pathophysiology and mechanisms

The Event

Event poster

ESC Congress 2019

1 September 2019 08:30 CET
You may be interested in
thumbnail
Congress Presentation
Plasma histidine as biomarker for recurrent atrial fibrillation after catheter ablation
1 September 2025
thumbnail
Congress Presentation
SDMA correlates with platelet reactivity and bleeding risk in patients with acute coronary syndrome undergoing percutaneous coronary intervention
29 June 2021
thumbnail
Congress Presentation
Microvascular dysfunction contributes to atrial fibrillation in hypertrophic cardiomyopathy, a multimodality study
11 December 2024
thumbnail
Congress Presentation
Differential effect of low-voltage area ablation on atrial tachycardia recurrence in diabetic versus non-diabetic patients with persistent atrial fibrillation: sub-analysis of the SUPPRESS-AF Trial
1 September 2025

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources